Pune, Maharashtra, ʻOkakopa 22 2020 (Wiredrelease) Graphical Research -: ʻO ka piʻi mau ʻana o ka nui o nā hihia COVID-19 i alakaʻi i ka koi ikaika no nā hopena ʻike virus. Hoʻohana ʻia nā pahu ʻike COVID-19 e nānā a ʻike i ka hele ʻana o ka maʻi SARS-CoV-2 i loko o kahi kanaka e lawe ana i ka maʻi.
Ma ka ʻāina ʻo Asia Pākīpika kahi e noho ai ʻo 60% o ka heluna o ka honua i nā wahi ākea, ke piʻi mau nei ka pilikia o COVID-19 ʻoiai nā hana hoʻopaʻa. ʻO ka piʻi nui ʻana o ka coronavirus ua hoʻohuli i nā ʻāina he nui o Asia Pacific e hana i nā hana koʻikoʻi a hoʻonui i ka hiki ke nānā a me ka hoʻāʻo.
Noi no kahi laʻana o kēia hōʻike @ https://www.graphicalresearch.com/request/1364/sample
ʻO ka loaʻa ʻana o nā hoʻoponopono aupuni maikaʻi a me ka piʻi ʻana o ka ʻike no nā hoʻokolohua coronavirus ua paipai i nā ʻoihana mālama olakino e hoʻonui i nā mana hana o nā pahu hoʻāʻo COVID-19. Ua hōʻike ʻia, manaʻo ʻia ka nui o ka mākeke ʻo Asia Pacific COVID-19 e ʻoi aku ma mua o US $ 1.8 biliona e 2026 e pili ana i ka uku makahiki. ʻO ka mea i haʻi ʻia ma lalo nei kekahi mau mea e alakaʻi nei i ka ʻike mākeke.
ʻO nā hana a ke aupuni e pale aku i ka COVID-19
Wahi a ka Indian Council of Medical Research (ICMR), hiki i nā hui lāʻau lapaʻau India ke hana a hāʻawi i nā kit diagnostic i nā hale hana aupuni a me nā pilikino ma hope o ka loaʻa ʻana mai ka National Institute of Virology (NIV). ʻAʻole pono nā ʻoihana e kali no ka ʻae ʻia mai ka CE o ʻEulopa a me ka US FDA ma mua o ka hāʻawi ʻana. ʻO nā hana like ma waena o Asia Pacific e pale i ka palena hoʻoponopono a kūʻē i ka laha ʻana o ka maʻi e hana i nā manawa no ka hoʻomohala ʻana a me ke kūʻai ʻana i nā pahu hoʻāʻo.
Hoʻonui ʻia ka noi no nā kits assay RT-PCR
ʻO ka ʻoihana pahu hoʻāʻo COVID-19, e pili ana i nā huahana, ua hoʻokaʻawale ʻia i loko o nā pahu hoʻāʻo immunoassay a me nā kits assay RT-PCR. ʻO ke ʻano hoʻāʻo RT-PCR he mea pane a maopopo loa i ke ʻano e kōkua i ka ʻike ʻana i ka hele ʻana o ka maʻi SARS-COV-2 i ka laʻana o ka mea maʻi. Ma ka ʻaoʻao ʻē aʻe, ʻo ke ʻano immunoassay-based e hāʻawi i nā hopena wikiwiki e koi pū kekahi i kahi hōʻoia post confirmatory me ka hoʻohana ʻana i ke ʻano RT-PCR. Ua hōʻike ʻia, manaʻo ʻia e piʻi aʻe ka mākeke ʻo APAC RT-PCR assay kits ma kahi o 20% CAGR i nā makahiki e hiki mai ana.
ʻO ka kikoʻī o nā swabs nasopharyngeal
Hoʻokaʻawale ʻia ka ʻoihana kits detection kits COVID-19 i loko o ka nasopharyngeal swab, nasal swab, oropharyngeal swab, a me nā ʻano specimen ʻē aʻe. Ma muli o ka kikoʻī kiʻekiʻe a me ka hua maikaʻi, ʻo ka ʻāpana nasopharyngeal swab e paʻa i ka māhele mākeke ma kahi o 45%, ke hoʻohālikelike ʻia me nā ʻano laʻana āpau. ʻOiai ka paʻa ʻana i kahi ʻāpana koʻikoʻi, ʻo nā pilikia me ka hoʻohana ʻana i ka nasal swab e pili ana i ka kikoʻī haʻahaʻa a me ka hua.
Manaʻo no ka hoʻāʻo ʻana ma nā kikowaena diagnostic
ʻO nā mea hoʻohana hope loa o nā pahu ʻike COVID-19 ma Asia Pacific he mau halemai a me nā kikowaena diagnostic. Kt koi ma waena o nā kikowaena diagnostic ua waiwai ʻia ma kahi o US $200 miliona ma 2020. ʻO kēia ma muli o ka hiki o nā hoʻokolohua ma kēia mau kikowaena. ʻO ka loaʻa ʻana o nā ʻoihana akamai a me nā mea hana kiʻekiʻe ma nā keʻena diagnostic hiki ke hoʻāʻo i kahi helu nui o nā laʻana.
ʻOiai ka loaʻa ʻana o ka nui o ka hoʻihoʻi hou ʻana ma kahi o 80% mai ka maʻi, ke ʻike nei ʻo India i kahi make nui ma muli o ka nele o nā ʻoihana olakino holomua. Me kahi kokoke i 1 miliona mau hoʻāʻo i kēlā me kēia lā, a me ke kākoʻo aupuni no nā hoʻomaka ʻana i komo i ka hoʻāʻo coronavirus hou e hoʻoikaika ai i nā kits ma ka ʻāina. Ua manaʻo ʻia ka nui o ka mākeke ʻike maka COVID-19 ma kahi CAGR o 28% a hiki i 2026. ʻO nā hana nui e hoʻoikaika i ka hiki ke hakakā i ka maʻi maʻi coronavirus, Kina, India, South Korea a me nā mea ʻē aʻe e hoʻonui ana i kā lākou manaʻo i ka hana ʻana i nā pahu hoʻāʻo.
ʻO nā hui alakaʻi e hāʻawi ana i nā pahu ʻike COVID-19 ma ka ʻāina ʻo Shenzhen Bioeasy Biotechnology, Co-Diagnostics, Cepheid, BioFire Diagnostics, Guangzhou Wondfo Biotech, F. Hoffmann-La Roche, Qiagen, Mylab Discovery Solutions, SD Biosensor, Thermo Fisher Scientific, Seegene , Abbott, a me BGI.
E nānā i nā ʻike ʻoihana nui me ka TOC holoʻokoʻa @ https://www.graphicalresearch.com/table-of-content/1364/asia-pacific-covid-19-detection-kits-market
E pili ana i ka noiʻi kiʻi:
He ʻimi noiʻi ʻoihana kiʻi e hāʻawi i ka ʻike ʻoihana, ka wānana mākeke a me nā hoʻokomo kumumanaʻo ma o nā hōʻike noiʻi granular a me nā lawelawe aʻoaʻo aʻoaʻo. Hoʻopuka mākou i nā hōʻike noiʻi i māka ʻia me ka pahuhopu e hoʻoponopono i nā makemake o nā mea kūʻai aku like ʻole, mai ke komo ʻana o ka mākeke a me nā hoʻolālā komo i ka hoʻokele kōpili a me ka nānā ʻana i ka hoʻolālā. Hoʻomaopopo mākou he ʻokoʻa nā koi o ka ʻoihana: kā mākou hōʻike syndicate i hoʻolālā ʻia e hōʻoia i ka pilina o nā mea ʻoihana i loko o ke kaulahao waiwai. Hāʻawi pū mākou i nā hōʻike pilikino i hoʻonohonoho ʻia i nā pono kikoʻī o ka mea kūʻai aku, me ke kākoʻo loiloi i hoʻolaʻa ʻia ma o ka lifecycle kūʻai.
Kāhea iā mā˚ou:
ʻO Parikhit B.
ʻOihana kūʻai aku,
ʻImi kiʻi
Email: [pale ʻia ka leka uila]
Web: https://www.graphicalresearch.com
Ua paʻi ʻia kēia ʻike e ka ʻoihana noiʻi kiʻi. ʻAʻole pili ka ʻOihana WiredRelease News Department i ka hoʻokumu ʻia ʻana o kēia ʻike. No ka ninaninau lawelawe hoʻokuʻu hoʻokuʻu, e ʻoluʻolu e kiʻi iā mākou ma [pale ʻia ka leka uila].
